1. Home
  2. IPSC vs MDAI Comparison

IPSC vs MDAI Comparison

Compare IPSC & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$0.92

Market Cap

58.3M

Sector

Health Care

ML Signal

HOLD

MDAI

Spectral AI Inc.

HOLD

Current Price

$1.62

Market Cap

47.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPSC
MDAI
Founded
2019
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.3M
47.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
IPSC
MDAI
Price
$0.92
$1.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$3.00
$3.25
AVG Volume (30 Days)
1.5M
290.9K
Earning Date
11-13-2025
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$113,337,000.00
$23,168,000.00
Revenue This Year
$1,590.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4122.69
N/A
52 Week Low
$0.34
$1.04
52 Week High
$1.19
$3.21

Technical Indicators

Market Signals
Indicator
IPSC
MDAI
Relative Strength Index (RSI) 61.52 54.71
Support Level $0.91 $1.41
Resistance Level $1.05 $1.47
Average True Range (ATR) 0.12 0.08
MACD 0.01 0.02
Stochastic Oscillator 66.72 91.07

Price Performance

Historical Comparison
IPSC
MDAI

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: